{
    "organizations": [],
    "uuid": "0debe765516035649e8038b7a591b1b0b14a140d",
    "author": "Reuters Editorial",
    "url": "https://www.reuters.com/article/brief-krystal-biotech-announces-fda-clea/brief-krystal-biotech-announces-fda-clearance-of-ind-on-kb103-for-the-treatment-of-dystrophic-epidermolysis-bullosa-idUSFWN1S30X9",
    "ord_in_thread": 0,
    "title": "Krystal Biotech Announces FDA Clearance Of IND On KB103 For The Treatment Of Dystrophic Epidermolysis Bullosa",
    "locations": [],
    "highlightText": "",
    "language": "english",
    "persons": [],
    "text": "April 26 (Reuters) - Krystal Biotech Inc:\n* KRYSTAL BIOTECH ANNOUNCES FDA CLEARANCE OF IND ON KB103 TO BEGIN ENROLLING PATIENTS FOR THE TREATMENT OF DYSTROPHIC EPIDERMOLYSIS BULLOSA\n* KRYSTAL BIOTECH INC - PLANNED PHASE 1/2 CLINICAL STUDY OF KB103 IS A SINGLE SITE STUDY AT STANFORD UNIVERSITY EXPECTED TO START IN MAY 2018\n* KRYSTAL BIOTECH INC - INITIAL DATA FROM STUDY OF KB103 ARE EXPECTED TO BE RELEASED BY END OF 2018 Source text for Eikon:\n ",
    "published": "2018-04-26T20:25:00.000+03:00",
    "crawled": "2018-04-27T16:35:42.063+03:00",
    "highlightTitle": "",
    "preprocessed_text": [
        "april",
        "reuters",
        "krystal",
        "biotech",
        "inc",
        "krystal",
        "biotech",
        "announces",
        "fda",
        "clearance",
        "ind",
        "kb103",
        "begin",
        "enrolling",
        "patient",
        "treatment",
        "dystrophic",
        "epidermolysis",
        "bullosa",
        "krystal",
        "biotech",
        "inc",
        "planned",
        "phase",
        "clinical",
        "study",
        "kb103",
        "single",
        "site",
        "study",
        "stanford",
        "university",
        "expected",
        "start",
        "may",
        "krystal",
        "biotech",
        "inc",
        "initial",
        "data",
        "study",
        "kb103",
        "expected",
        "released",
        "end",
        "source",
        "text",
        "eikon"
    ]
}